Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Antiandrogenicity

Environmental antiandrogens Vinclozolin Procymidone Kraft mill effluent... [Pg.51]

A highly modified methyl testosterone derivative also exhibits antiandrogenic activity. One synthesis of this compound Involves initial alkylation of methyl testosterone (3 ) by means of strong base and methyl iodide to afford the 4,4-dimethyl derivative Formylation with alkoxide and... [Pg.89]

ACE inhibitors do not completely block aldosterone synthesis. Since this steroid hormone is a potent inducer of fibrosis in the heart, specific antagonists, such as spironolactone and eplerenone, have recently been very successfully used in clinical trials in addition to ACE inhibitors to treat congestive heart failure [5]. Formerly, these drugs have only been applied as potassium-saving diuretics in oedematous diseases, hypertension, and hypokalemia as well as in primary hyperaldosteronism. Possible side effects of aldosterone antagonists include hyperkalemia and, in case of spironolactone, which is less specific for the mineralocorticoid receptor than eplerenone, also antiandrogenic and progestational actions. [Pg.1069]

SARMs are AR ligands that display tissue-specific androgenic/antiandrogenic activities. [Pg.1112]

ATC G03H L02BB02 Use non-steroidal antiandrogen (for treatment of prostatic carcinoma)... [Pg.1441]

Cyproterone acetate (CPA) is a progestational antiandrogen that blocks the androgen receptors. It is combined with ethinyl estradiol in an oral contraceptive formulation, which is indicated in female acne patients with a high level of seborrhea, therapy resistant papulo-pustular acne or acne conglobata not responding to other treatments. [Pg.131]

Spironolactone is an antiandrogen which blocks androgen-receptors, alters steroidogenesis by adrenals and gonads and inhibits 5-a reductase. In doses of 100-200 mg daily it reduces sebum production and improves inflammatory acne in women. During treatment, birth control measures are required due to the risk of male fetus feminization. [Pg.131]

Chemicals with antiandrogenic activity inclnde pharmacenticals developed as anticancer agents (e.g., flntamide, Neri and Monahan 1972 Neri et al. 1972, in Lntsky et al. 1975) and 179-methyltestosterone nsed to treat testosterone deficiency (Katsiadaki et al. 2006). Other antiandrogens inclnde varions pesticides snch as the... [Pg.267]

Baatrup, E. and Junge, M. (2001). Antiandrogenic pesticides disrupt sexual characteristics in the adult male guppy (Poecilia reticulata). Environmental Health Perspectives 109, 1063-1070. [Pg.338]

Gray, L.E. (1998). Tiered screening and testing strategy for xenoestrogens and antiandrogens. Toxicology Letters 103, 677-680. [Pg.349]

Gray, L.E., Ostby, J.S., and Kelce, W.R. (1994). Developmental effects of an environmental antiandrogen—the fungicide vinclozolin alters sex differentiation of the male rat. Toxicology and Applied Pharmacology 129,46-52. [Pg.349]

Gray, L.E., Ostby, J., and Wolf, C. et al. (1996). Effects of estrogenic, antiandrogenic and dioxin-like synthetic chemicals on mammalian sexual differentiation. Abstracts of Papers of the American Chemical Society 212,4—TOXI. [Pg.349]

Katsiadaki, I., Morris, S., and Squires, C. et al. (2006). Use of the three-spined stickleback (Gasterosteus aculeatus) as a sensitive in vivo test for detection of environmental antiandrogens. Environmental Health Perspectives 114, 115-121. [Pg.355]

Kelce, W.R., Monosson, E., and Gamcsik, M.P. et al. (1994). Environmental hormone disrupters—evidence that Vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicology and Applied Pharmacology 126, 276-285. [Pg.355]

Lutsky, B.N., Budak, M., and Koziol, P. (1975). The effects of a nonsteroid antiandrogen, flut-amide, on sebaceous gland activity. Journal Investigative Dermatology 64, 412 17. [Pg.358]

Neri, R.O. and Monahan, M. (1972). Effects of a novel nonsteroidal antiandrogen on canine prostatic hyperplasia. Investigative Urology 10, 123-130. [Pg.362]


See other pages where Antiandrogenicity is mentioned: [Pg.212]    [Pg.219]    [Pg.219]    [Pg.256]    [Pg.435]    [Pg.422]    [Pg.693]    [Pg.1133]    [Pg.390]    [Pg.1117]    [Pg.1117]    [Pg.1128]    [Pg.1130]    [Pg.587]    [Pg.241]    [Pg.243]    [Pg.567]    [Pg.915]    [Pg.267]    [Pg.269]    [Pg.269]    [Pg.271]    [Pg.271]    [Pg.273]    [Pg.274]    [Pg.276]    [Pg.279]    [Pg.281]    [Pg.282]    [Pg.283]    [Pg.289]    [Pg.369]    [Pg.714]    [Pg.745]    [Pg.965]   
See also in sourсe #XX -- [ Pg.45 ]




SEARCH



Androgens antiandrogens

Androgens, Anabolic Steroids, Antiandrogens

Antiandrogen

Antiandrogen therapy

Antiandrogen withdrawal syndrome

Antiandrogenic

Antiandrogenic agents

Antiandrogenic compounds

Antiandrogenic effects

Antiandrogens

Antiandrogens

Antiandrogens adverse effects

Antiandrogens benign prostatic hyperplasia

Antiandrogens bicalutamide

Antiandrogens cyproterone acetate

Antiandrogens finasteride

Antiandrogens flutamide

Antiandrogens in prostate cancer

Antiandrogens long-term effects

Antiandrogens toxicity

Chemicals with Antiandrogenic Activity (Xenoantiandrogens)

Contraceptives antiandrogenic effects

Nonsteroidal antiandrogen

Nonsteroidal antiandrogens

Oral contraceptives antiandrogenic effects

Prostate cancer antiandrogens

Steroidal antiandrogens

© 2024 chempedia.info